OXTRIPHYLLINE Drug Patent Profile
✉ Email this page to a colleague
When do Oxtriphylline patents expire, and when can generic versions of Oxtriphylline launch?
Oxtriphylline is a drug marketed by Morton Grove and Watson Labs and is included in four NDAs.
The generic ingredient in OXTRIPHYLLINE is oxtriphylline. There are three drug master file entries for this compound. Additional details are available on the oxtriphylline profile page.
Summary for OXTRIPHYLLINE
| US Patents: | 0 |
| Applicants: | 2 |
| NDAs: | 4 |
| Raw Ingredient (Bulk) Api Vendors: | 37 |
| Patent Applications: | 3,120 |
| Formulation / Manufacturing: | see details |
| DailyMed Link: | OXTRIPHYLLINE at DailyMed |
US Patents and Regulatory Information for OXTRIPHYLLINE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Morton Grove | OXTRIPHYLLINE | oxtriphylline | SOLUTION;ORAL | 088243-001 | Dec 5, 1983 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Morton Grove | OXTRIPHYLLINE PEDIATRIC | oxtriphylline | SYRUP;ORAL | 088242-001 | Dec 5, 1983 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Watson Labs | OXTRIPHYLLINE | oxtriphylline | TABLET, DELAYED RELEASE;ORAL | 087866-001 | Aug 25, 1983 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Watson Labs | OXTRIPHYLLINE | oxtriphylline | TABLET, DELAYED RELEASE;ORAL | 087835-001 | Aug 25, 1983 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
